NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/28/2023
Back to search
Official data from USPTO
HYBRID CONCEPTS INTERNATIONAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Quick snapshot
ST13
US500000097167024Class
35, 36, 42, 44
Filing
97167024
Registration
7009804
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
03/28/2023
Classification
Registered
Trademark type
Combined
Nice classes
35, 36, 42, 44
Filing date
12/10/2021
Registration date
03/28/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/28/2023
Last transaction
03/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/30/2017
First use in commerce
06/30/2017
Drawing code
3
Owner type
16
Owner location
GRAND ISLAND, NY
Examiner
MCBRIDE, THEODORE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words HYBRID CONCEPTS above the word INTERNATIONAL, the letter Os being atoms or cells within a molecular or cellular design.
Holders and representatives
Holders
HYBRID CONCEPTS INTERNATIONAL, LLC
Representatives
JOHN P. MURTAUGH PEARNE & GORDON LLP
Technical classification
Nice Classes
Class 35Class 36Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Assistanceadvisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesregulatory affairs including preclinicalclinical and commercial stagepharmaceutical preclinical and clinical researchdevelopmentchemistrymanufacturing and controlsquality assurance/quality control; Business consulting servicesproviding assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support servicesbusiness consulting to freelancersstart-upsexisting businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA productclinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigationresearch and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations
Class 36
Financial consulting servicesadvising others regarding intellectual property investments; Investment consultation in the fields of producttechnicalregulatorypreclinicalclinicalcommercial diligence for innovative potential or investigational medical products
Class 42
Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Medical and scientific research information in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesregulatory affairs including preclinicalclinical and commercial stagepharmaceutical preclinical and clinical researchdevelopmentmanufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological servicesscientific research in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesscientific research for preclinicalclinical and commercial stage pharmaceuticalspharmaceutical preclinical and clinical researchdevelopmentquality assurance/quality control; Scientific research consulting in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesscientific research for preclinicalclinical and commercial stage pharmaceuticalspharmaceutical preclinical and clinical researchdevelopmentquality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapygene therapygene editingxenotransplantationregenerative medicineadvanced therapiesadvanced therapeutic medicinal productsbiologicspharmaceuticalsmedical devicesscientific research for preclinicalclinical and commercial stage pharmaceuticalspharmaceutical preclinical and clinical researchdevelopmentquality assurance/quality control; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics
Class 44
Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2023
PUBO
PUBLISHED FOR OPPOSITION
01/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/30/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/17/2022
GNRT
NON-FINAL ACTION E-MAILED
11/17/2022
CNRT
NON-FINAL ACTION WRITTEN
11/17/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/11/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2022
DOCK
ASSIGNED TO EXAMINER
09/19/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2021
NWAP
NEW APPLICATION ENTERED
12/14/2021
Continuous trademark protection
Get notified about every new filing that threatens HYBRID CONCEPTS INTERNATIONAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.